Jamie Dananberg - Feb 18, 2025 Form 4 Insider Report for Annexon, Inc. (ANNX)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Jennifer Lew, Attorney-in-Fact
Stock symbol: ANNX
Transactions as of: Feb 18, 2025
Transactions value $: -$16,342
Form type: 4
Date filed: 2/20/2025, 04:54 PM
Previous filing: Feb 21, 2024
Next filing: Mar 3, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANNX	Common Stock	Sale	-$16.3K	-5.52K	-14.16%	$2.96	33.5K	Feb 18, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2	This transaction was executed in multiple trades in prices ranging from $2.855 to $3.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Content

The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

This transaction was executed in multiple trades in prices ranging from $2.855 to $3.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.